To evaluate whether the expression of CD1D, CD1B, and FCGRT is affected in a β2M-dependent manner in malignant melanoma, we first obtained the expression levels of all β2M-STRING-predicted interacting genes (n = 20) from the GDC-TCGA-SKCM study. This evidence concerns the gene B2M and melanoma.